Výsledky vyhledávání - "Abualainin W"

Zobrazeno 1 - 10 of 10 pro vyhledávání: '"Abualainin W"'

Řazení

Vybrat vše | Vybrané výsledky:

Vybrat výsledek číslo 1 1

Akademický článek

Qatar's genetic counseling landscape: Current insights and future prospects.

Autor: Abiib S; Department of Biomedical Sciences, College of Health Sciences, QU Health, Qatar University, Doha, Qatar., Khodjet-El-Khil H; Department of Biomedical Sciences, College of Health Sciences, QU Health, Qatar University, Doha, Qatar., El-Akouri K; Department of Adult and Pediatric Medical Genetics, Hamad Medical Corporation, Doha, Qatar.; Division of Genetic and Genomic Medicine, Sidra Medicine, Doha, Qatar., Bux RI; Department of Adult and Pediatric Medical Genetics, Hamad Medical Corporation, Doha, Qatar., Rezoug Z; Department of Biomedical Sciences, College of Health Sciences, QU Health, Qatar University, Doha, Qatar., Abualainin W; Diagnostic Genomic Division, Hamad Medical Corporation, Doha, Qatar., Alkowari M; Diagnostic Genomic Division, Hamad Medical Corporation, Doha, Qatar., Musa SO; Department of Adult and Pediatric Medical Genetics, Hamad Medical Corporation, Doha, Qatar.; Division of Genetic and Genomic Medicine, Sidra Medicine, Doha, Qatar., Al Mulla M; Department of Adult and Pediatric Medical Genetics, Hamad Medical Corporation, Doha, Qatar.; Division of Genetic and Genomic Medicine, Sidra Medicine, Doha, Qatar., Al Saleh R; Department of Adult and Pediatric Medical Genetics, Hamad Medical Corporation, Doha, Qatar.; Division of Genetic and Genomic Medicine, Sidra Medicine, Doha, Qatar., Shahbeck N; Department of Adult and Pediatric Medical Genetics, Hamad Medical Corporation, Doha, Qatar.; Division of Genetic and Genomic Medicine, Sidra Medicine, Doha, Qatar., Farag M; Division of Genetic and Genomic Medicine, Sidra Medicine, Doha, Qatar., Ismail SI; Qatar Genome Program, Qatar Foundation Research, Doha, Qatar., Al Sulaiman R; Department of Medical Oncology, National Center of Cancer Care and Research, Hamad Medical Corporation, Doha, Qatar., Ben-Omran T; Department of Adult and Pediatric Medical Genetics, Hamad Medical Corporation, Doha, Qatar.; Division of Genetic and Genomic Medicine, Sidra Medicine, Doha, Qatar., Al-Thani A; Department of Biomedical Sciences, College of Health Sciences, QU Health, Qatar University, Doha, Qatar.; Biomedical Research Center, Qatar University, Doha, Qatar., Al-Shafai M; Department of Biomedical Sciences, College of Health Sciences, QU Health, Qatar University, Doha, Qatar.; Biomedical Research Center, Qatar University, Doha, Qatar.

Publikováno v: Genetics in medicine open [Genet Med Open] 2024 Jul 06; Vol. 2 (Suppl 2), pp. 101866. Date of Electronic Publication: 2024 Jul 06 (Print Publication: 2024).

Zobrazit plný text záznamu

Vybrat výsledek číslo 2 2

Akademický článek

Serum immune mediators as novel predictors of response to anti-PD-1/PD-L1 therapy in non-small cell lung cancer patients with high tissue-PD-L1 expression.

Autor: Raza A; Department of Medical Oncology, National Center for Cancer Care and Research, Hamad Medical Corporation, Doha, Qatar.; Translational Cancer Research Facility, Translational Research Institute, Academic Health System, Hamad Medical Corporation, Doha, Qatar., Mohsen R; Department of Medical Oncology, National Center for Cancer Care and Research, Hamad Medical Corporation, Doha, Qatar., Kanbour A; Department of Medical Oncology, National Center for Cancer Care and Research, Hamad Medical Corporation, Doha, Qatar., Zar Gul AR; Department of Medical Oncology, National Center for Cancer Care and Research, Hamad Medical Corporation, Doha, Qatar., Philip A; Department of Medical Oncology, National Center for Cancer Care and Research, Hamad Medical Corporation, Doha, Qatar., Vijayakumar S; Department of Medical Oncology, National Center for Cancer Care and Research, Hamad Medical Corporation, Doha, Qatar., Hydrose S; Department of Medical Oncology, National Center for Cancer Care and Research, Hamad Medical Corporation, Doha, Qatar.; Translational Cancer Research Facility, Translational Research Institute, Academic Health System, Hamad Medical Corporation, Doha, Qatar., Prabhu KS; Translational Research Institute (TRI), Academic Health System, Hamad Medical Corporation, Doha, Qatar., Al-Suwaidi AK; Department of Medical Oncology, National Center for Cancer Care and Research, Hamad Medical Corporation, Doha, Qatar.; Translational Cancer Research Facility, Translational Research Institute, Academic Health System, Hamad Medical Corporation, Doha, Qatar., Inchakalody VP; Department of Medical Oncology, National Center for Cancer Care and Research, Hamad Medical Corporation, Doha, Qatar.; Translational Cancer Research Facility, Translational Research Institute, Academic Health System, Hamad Medical Corporation, Doha, Qatar., Merhi M; Department of Medical Oncology, National Center for Cancer Care and Research, Hamad Medical Corporation, Doha, Qatar.; Translational Cancer Research Facility, Translational Research Institute, Academic Health System, Hamad Medical Corporation, Doha, Qatar., Abo El-Ella DM; Department of Medical Oncology, National Center for Cancer Care and Research, Hamad Medical Corporation, Doha, Qatar.; Translational Cancer Research Facility, Translational Research Institute, Academic Health System, Hamad Medical Corporation, Doha, Qatar., Tauro MA; Department of Human Genetics, Sidra Medical and Research Center, Doha, Qatar., Akbar S; College of Health and Life Sciences, Hamad Bin Khalifa University, Doha, Qatar., Al-Bozom I; Department of Laboratory Medicine and Pathology, Hamad Medical Corporation, Doha, Qatar., Abualainin W; Diagnostic Genomic Division , Department of Laboratory Medicine and Pathology, Hamad Medical Corporation, Doha, Qatar., Al-Abdulla R; Department of Laboratory Medicine and Pathology, Hamad Medical Corporation, Doha, Qatar., Sirriya SA; Diagnostic Genomic Division , Department of Laboratory Medicine and Pathology, Hamad Medical Corporation, Doha, Qatar., Hassnad S; Department of Radiation Oncology, National Center for Cancer Care and Research, Hamad Medical Corporation, Doha, Qatar., Uddin S; Translational Research Institute and Dermatology Institute, Academic Health System, Hamad, Medical Corporation, Doha, Qatar.; Laboratory Animal Research Center, Qatar University, Doha, Qatar., Mohamed Ibrahim MI; Clinical Pharmacy and Practice Department, College of Pharmacy, Qatar University (QU) Health, Qatar University, Doha, Qatar., Al Homsi U; Department of Medical Oncology, National Center for Cancer Care and Research, Hamad Medical Corporation, Doha, Qatar., Demime S; Department of Medical Oncology, National Center for Cancer Care and Research, Hamad Medical Corporation, Doha, Qatar.; Translational Cancer Research Facility, Translational Research Institute, Academic Health System, Hamad Medical Corporation, Doha, Qatar.; College of Health and Life Sciences, Hamad Bin Khalifa University, Doha, Qatar.

Publikováno v: Frontiers in immunology [Front Immunol] 2023 May 15; Vol. 14, pp. 1157100. Date of Electronic Publication: 2023 May 15 (Print Publication: 2023).

Zobrazit plný text záznamu

Vybrat výsledek číslo 3 3

Akademický článek

Circulating exosomal immuno-oncological checkpoints and cytokines are potential biomarkers to monitor tumor response to anti-PD-1/PD-L1 therapy in non-small cell lung cancer patients.

Autor: Akbar S; College of Health and Life Sciences, Hamad Bin Khalifa University, Doha, Qatar., Raza A; Department of Medical Oncology, National Center for Cancer Care and Research, Hamad Medical Corporation, Doha, Qatar.; Translational Cancer Research Facility, Translational Research Institute, Academic Health System, Hamad Medical Corporation (HMC), Doha, Qatar., Mohsin R; Department of Medical Oncology, National Center for Cancer Care and Research, Hamad Medical Corporation, Doha, Qatar., Kanbour A; Department of Medical Oncology, National Center for Cancer Care and Research, Hamad Medical Corporation, Doha, Qatar., Qadri S; Irma Lerma Rangel College of Pharmacy, Texas A&M University, Kingsville, TX, United States., Parray A; Neuroscience Institute, Academic Health System, Hamad Medical Corporation, Doha, Qatar., Zar Gul AR; Department of Medical Oncology, National Center for Cancer Care and Research, Hamad Medical Corporation, Doha, Qatar., Philip A; Department of Medical Oncology, National Center for Cancer Care and Research, Hamad Medical Corporation, Doha, Qatar., Vijayakumar S; Department of Medical Oncology, National Center for Cancer Care and Research, Hamad Medical Corporation, Doha, Qatar., Merhi M; Department of Medical Oncology, National Center for Cancer Care and Research, Hamad Medical Corporation, Doha, Qatar.; Translational Cancer Research Facility, Translational Research Institute, Academic Health System, Hamad Medical Corporation (HMC), Doha, Qatar., Hydrose S; Department of Medical Oncology, National Center for Cancer Care and Research, Hamad Medical Corporation, Doha, Qatar.; Translational Cancer Research Facility, Translational Research Institute, Academic Health System, Hamad Medical Corporation (HMC), Doha, Qatar., Inchakalody VP; Department of Medical Oncology, National Center for Cancer Care and Research, Hamad Medical Corporation, Doha, Qatar.; Translational Cancer Research Facility, Translational Research Institute, Academic Health System, Hamad Medical Corporation (HMC), Doha, Qatar., Al-Abdulla R; Anatomical Pathology, Department of Laboratory Medicine and Pathology, Hamad Medical Corporation, Doha, Qatar., Abualainin W; Diagnostic Genomic Division, Solid Tumor Section, Department of Laboratory Medicine and Pathology, Hamad Medical Corporation, Doha, Qatar., Sirriya SA; Diagnostic Genomic Division, Department of Laboratory Medicine and Pathology, Hamad Medical Corporation, Doha, Qatar., Al-Bozom I; Anatomical Pathology, Department of Laboratory Medicine and Pathology, Hamad Medical Corporation, Doha, Qatar., Uddin S; Translational Research Institute and Dermatology Institute, Academic Health System, Hamad Medical Corporation, Doha, Qatar.; Laboratory Animal Research Center, Qatar University, Doha, Qatar., Khan OM; College of Health and Life Sciences, Hamad Bin Khalifa University, Doha, Qatar., Mohamed Ibrahim MI; Clinical Pharmacy and Practice Department, College of Pharmacy, QU Health, Qatar University, Doha, Qatar., Al Homsi U; Department of Medical Oncology, National Center for Cancer Care and Research, Hamad Medical Corporation, Doha, Qatar., Dermime S; College of Health and Life Sciences, Hamad Bin Khalifa University, Doha, Qatar.; Department of Medical Oncology, National Center for Cancer Care and Research, Hamad Medical Corporation, Doha, Qatar.; Translational Cancer Research Facility, Translational Research Institute, Academic Health System, Hamad Medical Corporation (HMC), Doha, Qatar.

Publikováno v: Frontiers in immunology [Front Immunol] 2023 Jan 18; Vol. 13, pp. 1097117. Date of Electronic Publication: 2023 Jan 18 (Print Publication: 2022).

Zobrazit plný text záznamu

Vybrat výsledek číslo 4 4

Report

Leptomeningeal Metastatic L858R EGFR -mutant Lung Cancer: Prompt Response to Osimertinib in the Absence of T790M-mutation and Effective Subsequent Pulsed Erlotinib.

Autor: Kanbour A; Medical Oncology Department, National Center for Cancer Care and Research, Hamad Medical Corporation, Doha, Qatar., Salih F; Medical Oncology Department, National Center for Cancer Care and Research, Hamad Medical Corporation, Doha, Qatar., Abualainin W; Solid Tumor Section, Molecular Genetics Laboratory, Diagnostic Genomic Division, Department of Laboratory Medicine and Pathology, Hamad Medical Corporation, Doha, Qatar., Abdelrazek M; Clinical Imaging Department, National Center for Cancer Care and Research, Hamad Medical Corporation, Doha, Qatar., Szabados L; Clinical Imaging Department, National Center for Cancer Care and Research, Hamad Medical Corporation, Doha, Qatar., Al-Bozom I; Precision Medicine Section, Anatomical Pathology Department, Department of Laboratory Medicine and Pathology, Hamad Medical Corporation, Doha, Qatar., Omar NE; Pharmacy Department, National Center for Cancer Care and Research, Hamad Medical Corporation, Doha, Qatar.

Publikováno v: OncoTargets and therapy [Onco Targets Ther] 2022 Jun 14; Vol. 15, pp. 659-667. Date of Electronic Publication: 2022 Jun 14 (Print Publication: 2022).

Zobrazit plný text záznamu

Plný text ve formátu HTML

Vybrat výsledek číslo 5 5

Akademický článek

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Vybrat výsledek číslo 6 6

Akademický článek

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Vybrat výsledek číslo 7 7

Akademický článek

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Vybrat výsledek číslo 8 8